The deal hands Amgen a drug that destroys two proteins known to drive certain types of acute myeloid leukemia, a profile that ...
Have you ever felt like your once-speedy Windows 11 PC has turned into a sluggish, unresponsive machine? It’s frustrating, isn’t it? Whether you’re trying to meet a deadline, enjoy a seamless gaming ...
A new program that aims to connect startups with community health organizations and health care providers has received a $500,000 injection from the Walton Family Foundation. HealthTech Arkansas, an ...
Regeneron Pharmaceuticals is putting more money into gene editing, announcing Monday a partnership with Tessera Therapeutics to develop an experimental program for a rare liver and lung disease. At ...
Editas Medicine (NASDAQ:EDIT) is one of the best gene-editing stocks to buy according to hedge funds. On November 10, 2025, Clear Street raised its price target on Editas Medicine (NASDAQ:EDIT) to ...
A Trump administration pilot program aims for three nuclear startups to reach a key milestone by July 4, 2026. Valar Atomics says it’s the first to do so—but it had some help. It’s also, more ...
Western Slope school districts could gain — or miss out — on a share of state funds to expand high school career readiness programs, depending on how the Colorado State Board of Education decides to ...
A Silicon Valley startup backed by OpenAI’s Sam Altman and Coinbase’s Brian Armstrong is pursuing research that some fear could lead to the birth of a genetically engineered baby — a step that’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results